In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Genetic analysis specialist Sequenom nets $92mm in public offer
08 Jul 2008
Sequenom (platforms for genetic research and molecular diagnostics) netted $92mm through the follow-on public sale of 6.3mm shares (including the overallotment) at $15.50 each. The company will put the money towards developing noninvasive diagnostics that use its nucleic acid analysis system MassARRAY. Under a license from the Chinese University of Hong Kong, Sequenom is initially focusing on prenatal testing to identify fetal gene and chromosome abnormalities.
Research, Analytical Equipment & Supplies
In Vitro Diagnostics
Molecular Diagnostics & Genetic Testing
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?